THE EFFECT OF STEROID THERAPY ON BONE TISSUE IN RHEUMATIC DISEASES (DESCRIPTION OF A CLINICAL CASE)
Joint and bone pain is the most common symptom of most joint pathologies of inflammatory autoimmune nature. In patients with diagnosed rheumatic disease undergoing hormonal therapy, it can be regarded as an exacerbation of the underlying disease, and not as a symptom of secondary osteoporosis.
The article presents a clinical case of a patient with mixed connective tissue disease (systemic lupus erythematosus + juvenile idiopathic arthritis), who was referred for hospitalization due to deterioration of health in the form of severe arthralgia and myalgia against the background of glucocorticoid therapy.
Rymbaeva Tamara Khamitovna – Candidate of Medical Sciences, Associate Professor of the Department of Internal Diseases and Rheumatology, NCJSC “Semey Medical University.” Phone: +7 777 999 9159 Email: t_rymbaeva@mail.ru ORCID: 0000-0003-3769-6796
Kanapiyanova Gulnur Bolatbekovna – PhD Candidate, NCJSC “Semey Medical University.” Phone: +7 775 177 9375 ORCID: 0000-0002-8102-5220
Madieva Madina Rashidovna – Doctor of Medical Sciences, Professor, Head of the Department of Radiology, NCJSC “Semey Medical University,” Semey, Kazakhstan. Phone: +7 708 524 4745 ORCID: 0000-0001-6431-9713
Kaskabayeva Alida Sharipovna – Candidate of Medical Sciences, Professor, Head of the Department of Internal Diseases and Rheumatology, NCJSC “Semey Medical University,” Semey, Kazakhstan. Phone: +7 777 267 5521 ORCID: 0000-0002-5184-214X
Goremykina Maiya Valentinovna – Candidate of Medical Sciences, Associate Professor of the Department of Internal Diseases and Rheumatology, NCJSC “Semey Medical University.” Phone: +7 777 390 8234 ORCID: 0000-0002-5433-7771
Bersimbekova Gulzhan Baltabekovna – PhD Candidate, NCJSC “Semey Medical University.” Phone: +7 702 372 8412 ORCID: 0000-0002-9416-5054
1. Belaya Zh.E., Belova K.Yu., Biryukova E.V., Dedov I.I., Dzeranova L.K., et al. Federal clinical guidelines for the diagnosis, treatment, and prevention of osteoporosis. Osteoporosis and Osteopathy. 2021. 24(2):4–47.
2. Lesnyak O.M., Baranova I.A., Toroptsova N.V. Glucocorticoid-induced osteoporosis in adults. Yaroslavl: “Litera”, 2021. 13 p.
3. Pochkaylo A.S., Galashevskaya A.A., Vodyanova O.V. Osteoporosis in pediatric practice: modern approaches to medical prevention, diagnosis, and treatment: educational-methodological manual. Minsk: BelMAPO, 2022. 94 p.
4. Toroptsova N.V., Nasonov E.L. Review of the 2022 American College of Rheumatology (ACR) guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: what's new? Scientific and Practical Rheumatology. 2024. 62(2):145–153.
5. Chanakul A., Khunrattanaphon S., Deekajorndech T. Low bone mineral density in Thai children with systemic lupus erythematosus: prevalence and risk factors. Asian Biomed (Res Rev News). 2021 Oct 29;15(5):245–250. doi:10.2478/abm-2021-0030. PMID: 37551322. PMCID: PMC10388791.
6. Ciancia S., Högler W., Sakkers R.J.B., Appelman-Dijkstra N.M., Boot A.M., et al. Osteoporosis in children and adolescents: how to treat and monitor? European Journal of Pediatrics. 2023 Feb. 182(2):501–511. doi:10.1007/s00431-022-04743-x. Epub 2022 Dec 6.
7. Ciancia S., van Rijn R.R., Högler W., Appelman-Dijkstra N.M., Boot A.M., Sas T.C.J., Renes J.S. Osteoporosis in children and adolescents: when to suspect and how to diagnose it. European Journal of Pediatrics. 2022 Jul;181(7):2549–2561. doi:10.1007/s00431-022-04455-2. Epub 2022 Apr 6. PMID: 35384509; PMCID: PMC9192469.
8. Cipolla C., Sodero G., Cammisa I., Turriziani Colonna A., et al. The impact of glucocorticoids on bone health and growth: endocrine and non-endocrine effects in children and young patients. Minerva Pediatrics (Torino). 2023 Dec;75(6):896–904. doi:10.23736/S2724-5276.22.07074-4. Epub 2022 Oct 31. PMID: 36315414.
9. Cranney A., Welch V., Adachi J.D., et al. Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis. The Cochrane Library. 2004. Issue 1: CD001983.
10. Galindo-Zavala R., Bou-Torrent R., Magallares-López B., et al. Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children. Pediatric Rheumatology Online Journal. 2020 Feb 24. 18(1):20. doi:10.1186/s12969-020-0411-9. PMID: 32093703; PMCID: PMC7041118.
11. Hua J., Huang J., Li G., Lin S., Cui L. Glucocorticoid-induced bone disorders in children: research progress in treatment mechanisms. Frontiers in Endocrinology (Lausanne). 2023 Apr 4. 14:1119427. doi:10.3389/fendo.2023.1119427. PMID: 37082116; PMCID: PMC10111257.
12. Jin H.Y., Lee J.A. Low bone mineral density in children and adolescents with cancer. Annals of Pediatric Endocrinology & Metabolism. 2020 Sep;25(3):137–144. doi:10.6065/apem.2040060.030. Epub 2020 Sep 30. PMID: 33017885; PMCID: PMC7538298.
13. Sakka S.D. Osteoporosis in children and young adults. Best Practice & Research Clinical Rheumatology. 2022 Sep;36(3):101776. doi:10.1016/j.berh.2022.101776. Epub 2022 Sep 13. PMID: 36109301.
14. Soti Khiabani M., Tahghighi Sharabian F., Raeeskarami S.R., Ziaee V. Evaluation of bone mineral density in juvenile systemic lupus erythematosus. Archives of Bone and Joint Surgery. 2023. 11(12):777–782. doi:10.22038/ABJS.2023.70697.3311. PMID: 38146515; PMCID: PMC10748809.
Количество просмотров: 55
Категория статей:
Клинический случай
Библиографическая ссылка
Rymbayeva T.Kh., Кanapiyanova G.B., Маdievа M.R., Каskabayevа А.Sh., Bersimbekovа G.B., Goremykina M. The effect of steroid therapy on bone tissue in rheumatic diseases (description of a clinical case) // Nauka i Zdravookhranenie [Science & Healthcare]. 2025. Vol.27 (3), pp. 280-284. doi 10.34689/SH.2025.27.3.030Похожие публикации:
EXTRAPULMONARY TUBERCULOSIS IN A KAZAKH PATIENT WITH MIXED CONNECTIVE TISSUE DISEASE. СLINICAL CASE
THE EFFECT OF STEROID THERAPY ON BONE TISSUE IN RHEUMATIC DISEASES (DESCRIPTION OF A CLINICAL CASE)
A CLINICAL CASE OF ECHINOCOCCOSIS OF THE SPINE
DRUG-INDUCED LIVER DAMAGE. CLINICAL CASE
КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ БОЛЕЗНИ БЕХЧЕТА У ЖЕНЩИНЫ 36 ЛЕТ